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LpT2N0M0 esophageal squamous cell cancer: Location, grade, and
statisticsThomas W. Rice, MD, and Eugene H. Blackstone, MDFIGURE 1. Stage groupings for T2N0M0 esophageal squamous cell
carcinoma by cancer location and histologic grade (G). G1 is
well-differentiated histologic grade, and G2-3 is moderately or poorly
differentiated.Before the 7th edition of the American Joint Committee on
Cancer/International Union Against Cancer staging of
cancer of the esophagus and esophagogastric junction, all
esophageal cancer staging was empirical and relied solely
on anatomic cancer characteristics (TNM).1 Situ and col-
leagues2 have addressed the most complex interplay of
TNM and nonanatomic cancer characteristics included in
the 7th edition: pT2N0M0 squamous cell cancer
(Figure 1). Stage for stage, survival of patients with esoph-
ageal squamous cell cancer is worse than for those with
adenocarcinoma, and for early and intermediate stage
groupings it is dependent on both cancer location and histo-
logic grade. Despite being unable to discriminate a survival
difference among the 3 stage subgroupings to which
a pT2N0M0 squamous cell cancer could belong, we find
their analysis to be reassuring.
The 7th edition stage groupings were derived with
random forest analysis, a machine learning technique
that focuses on predictiveness for future patients.3,4
Random forest analysis makes no a priori assumptions
about survival, is able to identify complex interactions
among variables, and accounts for nonlinear effects.
Situ and colleagues2 have examined goodness of fit or
used P values to test for a statistically significant effect
of stage on survival, assumed linear effects, and per-
formed limited exploration of interactions. These funda-
mental differences in statistical methodology reflect the
different purposes of the original staging effort and
this recent assessment of pT2N0M0 esophageal squa-
mous cell cancer.
Acquisition of data was key to the 7th edition and was
a worldwide effort, with 4627 patients undergoing esoph-
agectomy analyzed.5 Situ and colleagues2 identify 317 pa-
tients, 26 in stage IB but most (291) in stage II (96 in
stage IIA and 131 in stage IIB). This distribution imbal-
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and IIIB esophageal squamous cell cancer. In the 7th edi-
tion, squamous cell esophageal cancer location is either
lower esophagus or not, and histopathologic grade is ei-
ther well differentiated or not. In Situ and colleagues,2
cancer location, which was retrospectively acquired, was
lower in 58 (18%), and histologic grade was well differ-
entiated in 121 (38%). Even if they dichotomized these
variables and only considered the 3 identified combina-
tions of cancer location and histopathologic grade (lower
and well differentiated, stage IB; not lower but well dif-
ferentiated or lower and not well differentiated, stage
IIA; and not lower and not well differentiated, stage
IIB), there might still be insufficient numbers of patients
to detect a survival difference. In their multivariable anal-
ysis, however, histologic grade was a significant predictor
of survival. Analysis of this small series, when corrected
for the dominant effect of grade, revealed an association
of cancer location with survival for well-differentiated
squamous cell cancers.
Despite the small size of the series, complexities of in-
teractions, and reliance on simple statistics, these find-
ings are reassuring and lead us to conclude, unlike Situ
and colleagues,2 that for pT2N0M0 squamous cell esoph-
ageal cancers, the 7th edition predicts survival better thangery c June 2013
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the 8th edition.
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